Cite
MLA Citation
B. Lim et al.. “Novel combination of AR inhibitor and CDK4/6 inhibitor, MEK inhibitor in non-HR positive breast cancers.” European journal of cancer, vol. 92, n.d., pp. S14–S15. http://access.bl.uk/ark:/81055/vdc_100060709659.0x000025